These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 2494462)
21. Acute myocardial infarction and the use of thrombolytic therapy. Betts B Qld Nurse; 1989; 8(2):12-4. PubMed ID: 2501830 [No Abstract] [Full Text] [Related]
23. Anistreplase for acute coronary thrombosis. Med Lett Drugs Ther; 1990 Feb; 32(812):15-6. PubMed ID: 2406552 [No Abstract] [Full Text] [Related]
24. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?]. Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962 [TBL] [Abstract][Full Text] [Related]
25. [Experience with the thrombolytic therapy of myocardial infarct]. Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835 [No Abstract] [Full Text] [Related]
28. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction. Kent DM; Vijan S; Hayward RA; Griffith JL; Beshansky JR; Selker HP J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737 [TBL] [Abstract][Full Text] [Related]
29. A symposium: Early intervention in the treatment of acute myocardial infarction--clinical profile of Eminase (APSAC). November 12, 1988, Washington, D.C. Am J Cardiol; 1989 Jul; 64(2):1A-42A. PubMed ID: 2662736 [No Abstract] [Full Text] [Related]
31. [Thrombolysis in the acute stage of myocardial infarction]. Dereppe H; Renard M; Bernard R Rev Med Brux; 1990 May; 11(5):149-54. PubMed ID: 2112774 [TBL] [Abstract][Full Text] [Related]
32. Thrombolytic agents in acute myocardial infarction. Rapaport E N Engl J Med; 1989 Mar; 320(13):861-4. PubMed ID: 2494455 [No Abstract] [Full Text] [Related]
33. Anistreplase (APSAC): a clinical investigator's update. A symposium. Bermuda, August 1989. Proceedings. Clin Cardiol; 1990 Mar; Suppl 5():V1-72. PubMed ID: 2182233 [No Abstract] [Full Text] [Related]
35. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent? Handlin LR; Vacek JL Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861 [TBL] [Abstract][Full Text] [Related]
36. Summary of U.S. clinical trials program for evaluation of anistreplase. Anderson JL Clin Cardiol; 1990 Mar; Suppl 5():V33-8; discussion V67-72. PubMed ID: 2182239 [TBL] [Abstract][Full Text] [Related]
37. Anistreplase: a novel thrombolytic agent for acute myocardial infarction. Marinac JS; North DS; Stringer KA DICP; 1990 Jun; 24(6):607-15. PubMed ID: 2193460 [TBL] [Abstract][Full Text] [Related]
39. Myocardial salvage: thrombolytic therapy. Sternbach G; Tintinalli JE Emerg Med Clin North Am; 1988 May; 6(2):351-9. PubMed ID: 3127194 [TBL] [Abstract][Full Text] [Related]
40. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results]. Slama M; Cohen-Solal A; Spriet A Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]